<section id ="1156053-1174009" class="mfp-hide modal-dialog modal-content overlay-def"><header class="modal-header"><h2 class="modal-title">2019, c. 29, s. 167</h2></header><div class="modal-body"><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span><span class="HistoricalNote">2014, c. 24, s. 3</span></p><p class="Section amending" id="1156053"><strong><a class="sectionLabel" id="s-167"><span class="sectionLabel">167</span></a></strong> Section 21.7 of the Act is replaced by the following:</p><section><div class="AmendedText"><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Terms and conditions of authorizations</p><p class="Section"><strong>21.7</strong> The holder of a therapeutic product authorization shall comply with any terms and conditions of the authorization that are imposed by the Minister under subsection 21.92(3) or under regulations made under paragraph 30(1.2)(b).</p></div></section></div></section>